Obesity in bipolar disorder: an overview (Q38035727)

27 August 2017

Obesity in bipolar disorder: an overview (English)

1 reference

27 August 2017

0 references

1 reference

1

Susan L McElroy

1 reference

27 August 2017

2

Paul E Keck

1 reference

PubMed ID

22903246

27 August 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Current Psychiatry Reports

27 August 2017

1 reference

27 August 2017

14

1 reference

27 August 2017

6

1 reference

27 August 2017

650-658

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-012-0313-8

27 August 2017

0 references

cites work

Obesity in patients with severe mental illness: overview and management

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Body-Mass Index and Mortality among 1.46 Million White Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Obesity, leptin, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Recent advances in metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Increases in morbid obesity in the USA: 2000-2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Predictors of increasing waist circumference in an Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Ten putative contributors to the obesity epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Preliminary findings regarding overweight and obesity in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Childhood parental loss and bipolar spectrum in obese bariatric surgery candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Association between obesity and psychiatric disorders in the US adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

The burden of obesity among adults with bipolar disorder in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Excess mortality in bipolar and unipolar disorder in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Insulin dysfunction and allostatic load in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Burden of general medical conditions among individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Obesity as a correlate of outcome in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Early predictors of substantial weight gain in bipolar patients treated with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Prevalence and correlates of eating disorders in 875 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

BMI predicts emotion-driven impulsivity and cognitive inflexibility in adolescents with excess weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Weighing in the role of BDNF in the central control of eating behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Striatal dopamine transporter availability in unmedicated bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

High-fat diet selectively protects against the effects of chronic social stress in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Impaired CNS leptin action is implicated in depression associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Depression and other mental disorders in the relatives of morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

The emerging link between alcoholism risk and obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Addictive genes and the relationship to obesity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Dietary therapy for obesity: an emperor with no clothes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Lifestyle change and mobility in obese adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Depressive symptoms and inflammation increase in a prospective study of older adults: a protective effect of a healthy (Mediterranean-style) diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Integrating physical activity into mental health services for persons with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Exercise and bipolar disorder: a review of neurobiological mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

'It's a double edged sword': a qualitative analysis of the experiences of exercise amongst people with Bipolar Disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Pharmacological management of binge eating disorder: current and emerging treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Pharmacotherapies for obesity: past, current, and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Pharmacological treatment of the overweight patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Amantadine for weight gain associated with olanzapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Bariatric surgery: 1-year weight loss outcomes in patients with bipolar and other psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0313-8

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

21 January 2018

1 reference

12 December 2020

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders

1 reference

12 December 2020

A single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adults.

1 reference

12 December 2020

Are mood disorders and obesity related? A review for the mental health professional.

1 reference

12 December 2020

Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial

1 reference

12 December 2020

Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions.

1 reference

12 December 2020

A case of successful treatment of comorbid obesity and polycystic ovarian disease with add-on metformin in bipolar disorder

1 reference

12 December 2020

Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial.

1 reference

12 December 2020

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

1 reference

12 December 2020

Correlates of overweight and obesity in 644 patients with bipolar disorder

1 reference

12 December 2020

Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder

1 reference

12 December 2020

The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania

1 reference

12 December 2020

Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey

1 reference

12 December 2020

Interventions to reduce weight gain in schizophrenia

1 reference

12 December 2020

Determinants of overweight and obesity in patients with bipolar disorder.

1 reference

12 December 2020

Suicide attempts and ideation in patients with bipolar I disorder.

1 reference

12 December 2020

Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.

1 reference

12 December 2020

10.1007/S11920-012-0313-8

Identifiers

DOI

1 reference

PubMed ID

22903246

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22903246